Search research articles
Contact Us
Filters
Showing results (11-20 of 198) with videos related to
Page
of 20
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 20, 2002
High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy
G F Watts, P H Barrett
Atherosclerosis
|
December 24, 1998
Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis
G F Watts, D A Playford
QJM : Monthly Journal of the Association of Physicians
|
March 1, 2006
Apolipoproteins as markers and managers of coronary risk
D C Chan, G F Watts
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 24, 2008
Of mice and men: blowing away the cobwebs from the mechanism of action of niacin on HDL metabolism
G F Watts, D C Chan
Atherosclerosis
|
November 2, 2001
HDL kinetics, fish oils and diabetes
P H Barrett, G F Watts
Diabetes, Obesity & Metabolism
|
June 20, 2001
Therapeutic considerations for postprandial dyslipidaemia
J R Burnett, G F Watts
Clinical Chemistry
|
January 1, 1995
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease
M H Cummings, G F Watts
Annals of Clinical Biochemistry
|
March 1, 1992
Clinical and metabolic findings in a patient with phytosterolaemia
G F Watts, W D Mitchell
Clinical and Experimental Pharmacology & Physiology
|
July 23, 1998
Special article: non-invasive measurement of endothelial function
D A Playford, G F Watts
Journal of the Royal Society of Medicine
|
February 1, 1993
Measurement of apolipoproteins in the diabetic clinic
J C Mazurkiewicz, G F Watts
Page
of 20
Search research articles
Search
Showing results (11-20 of 198) with videos related to
Sort By:
Page
of 20
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 20, 2002
High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy
G F Watts, P H Barrett
Atherosclerosis
|
December 24, 1998
Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis
G F Watts, D A Playford
QJM : Monthly Journal of the Association of Physicians
|
March 1, 2006
Apolipoproteins as markers and managers of coronary risk
D C Chan, G F Watts
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 24, 2008
Of mice and men: blowing away the cobwebs from the mechanism of action of niacin on HDL metabolism
G F Watts, D C Chan
Atherosclerosis
|
November 2, 2001
HDL kinetics, fish oils and diabetes
P H Barrett, G F Watts
Diabetes, Obesity & Metabolism
|
June 20, 2001
Therapeutic considerations for postprandial dyslipidaemia
J R Burnett, G F Watts
Clinical Chemistry
|
January 1, 1995
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease
M H Cummings, G F Watts
Annals of Clinical Biochemistry
|
March 1, 1992
Clinical and metabolic findings in a patient with phytosterolaemia
G F Watts, W D Mitchell
Clinical and Experimental Pharmacology & Physiology
|
July 23, 1998
Special article: non-invasive measurement of endothelial function
D A Playford, G F Watts
Journal of the Royal Society of Medicine
|
February 1, 1993
Measurement of apolipoproteins in the diabetic clinic
J C Mazurkiewicz, G F Watts
Page
of 20